Proton

Generic Name :  Inj.Oxaliplatin

Packing :  Single Vial

Indication and dosage :
Early-stage colon cancer
Metastatic colorectal cancer
Recommended dose is 85 mg/m² IV over two hours, on an every-two-week schedule. Can also administer 130 mg/m² IV over six hours, on an every-three-week schedule

Therapeutic Segement :
Antineoplastic Agents

Our Brand Name :
XPLATIN

Strenghts :
50MG/25ML, 100MG/50ML

Generic Name :  Inj.Ifosfamide with Mesna

Packing :  Single Vial

Indication and dosage :
Testicular cancer: 1,200 mg/m² IV on days 1–5 every 21 days, as part of the VeIP salvage regimen.
Soft tissue sarcoma: 2,000 mg/m² IV continuous infusion on days 1–3 every 21 days, as part of the MAID regimen.
Non-Hodgkin's lymphoma: 1,000 mg/m2 on days 1 and 2 every 28 days, as part of the ICE regimen.
Head and neck cancer: 1,000 mg/m² on days 1–3 every 21–28 days, as part of the TIC regimen.

Therapeutic Segement :
Antineoplastic Agents

Our Brand Name :
SOLOXAN

Strenghts :
500MG combipack
1GM combipack
2GM combipack

Generic Name :  Inj. Doxorubicin Hydrochloridenj.

Packing :  Single Vial

Indication and dosage :
Acute myelogenous leukemia—30 mg IV on days 1,2&3

Acute lymphoblastic leukemia—30 mg IV on days 1

Breast cancer-Doxorubicin 50mg\m² IV on day 1 Repeat cycle every 21 days in AT Regimen

1.Single agent: 60–75 mg/m² IV every three weeks.
2.Single agent: 15–20 mg/m² IV weekly.
3.Combination therapy: 45–60 mg/m² every three weeks.
4.Continuous infusion: 60–90 mg/m² IV over 96 hours.

Therapeutic Segement :
Antineoplastic Agents

Our Brand Name :
ADROSOL ALSO AVAILABLE AS ADROSOL-RD

Strenghts :
10MG LYOPHILIZED VIAL
50MG LYOPHILIZED VIAL

Generic Name :  Inj. Amphotericin B

Packing :  Single Vial

Indication and dosage :
Indicated for the treatment of invasive fungal infections in patients who are refractory to or intolerant of conventional amphotericin B therapy. This is based on open-label treatment of patients judged by their physicians to be intolerant to or failing conventional amphotericin B therapy

For adults and children is 5 mg/kg given as a single infusion. Should be administered by intravenous infusion at a rate of 2.5 mg/kg/h.

Therapeutic Segement :
Antineoplastic Agents

Our Brand Name :
MYCOL

Strenghts :
50 MG SINGLE VIAL

Generic Name :  Cap. Hydroxyurea

Packing :  15*6 CAPSULES

Indication and dosage :
Chronic myelogenous leukemia.
Essential thrombocytosis.
Polycythemia vera.
Acute myelogenous leukemia, blast crisis
Head and neck cancer (in combination with radiation therapy)
Refractory ovarian cancer.

Continuous therapy: 20–30 mg/kg PO daily.
Intermittent therapy: 80 mg/kg PO every third day.
Combination therapy with irradiation of head and neck cancer: 80 mg/kg PO every third day.

Therapeutic Segement :
Antineoplastic Agents

Our Brand Name :
NEODREA

Strenght :
500 MG

Generic Name :  Inj.Dacarbazine

Packing :  Single Vial

Indication and dosage :
Metastatic malignant melanoma.
Hodgkin's disease.
Soft tissue sarcomas.
Neuroblastoma.

1. Hodgkin's disease: 375 mg/m2 IV on days 1 and 15 every 28 days, as part of the ABVD regimen.Continuous therapy: 20–30 mg/kg PO daily.
2. Melanoma: 220 mg/m2 IV on days 1–3 and days 22–24 every 6 weeks, as part of the Dartmouth regimen. As a single agent, 250 mg/m2 IV for five days or 800–1,000 mg/m2 IV every three weeks.

Therapeutic Segement :
Antineoplastic Agents

Our Brand Name :
ONCODAC

Strenght :
100 MG SINGLE LYOPHILIZED VIAL
200 MG SINGLE LYOPHILIZED VIAL
500 MG SINGLE LYOPHILIZED VIAL

Generic Name :  Inj. Cisplatin I.P

Packing :  Single Vial

Indication & Dosages :
Ovarian cancer: 75 mg/m2 IV on day one every 21 days
Testicular cancer: 20 mg/m2 IV on days 1–5 every 21 days
Head and neck cancer: 20 mg/m2/day IV continuous infusion for four days.
Non-small lung cancer: 60–100 mg/m2 IV on day one every 21 days
Bladder Cancer: 75mg/m2 IV on day 1.
Non Hodgkin's Lymphoma: 40mg/m2 IV on days 1,8 & 15

Therapeutic Segement :
Platinum analog

Our Brand Name :
PLATIFIRST INJ.

Strength :
PLATIFIRST INJ. 10MG & PLATIFIRST INJ. 50MG

Generic Name :  Inj.Paclitaxel

Packing :  Single Vial

Indication & Dosages:
Ovarian cancer: 135–175 mg/m2 IV as a 3-hour infusion every three weeks.
Breast cancer: 175 mg/m2 IV as a 3-hour infusion every three weeks.
Bladder cancer, head and neck cancer: 250 mg/m2 IV as a 24-hour infusion every three weeks.

Non - small cell lung cancer.
Combination regimen:175mg/m2 IV over 3 hours on day 1.Repeat cycle every 21 days.
Single - Agent regimens:80-100mg/m2 IV weekly for 3 weeks.

Esophageal cancer:
Combination regimen: 135mg/m2 IV for 24 hours on day 1 in adjuvant chemoyherapy. 200mg/m2 IV over 24 hours on day 1 in metastatic disease.
Sinle-Agent regimens: 250mg/m2 IV over 24 hours on day 1.

Therapeutic Segement :
Taxane, antimicrotubule agent

Our Brand Name :
NEOTAXL

Strength :
NEOTAXL 30MG/5ML,NEOTAXL 100MG/16.67ML,NEOTAXL 260MG/43.34ML,NEOTAXL 300MG/50ML & NEOTACL 250MG/